Acute graft-versus-host disease after liver transplant: Novel use of etanercept and the role of tumor necrosis factor α inhibitors

Liver Transplantation

Volumn 15, Issue 4, 2009, Pages 421-426

  Thin, Lena ^a   MacQuillan, Gerry ^a,b   Adams, Leon ^a,b   Garas, George ^a   Seow, Cynthia ^a   Cannell, Paul ^c   Augustson, Bradley ^a   Mitchell, Andrew ^a   Delriveire, Luc ^a   Jeffrey, Gary ^a,b  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; ANTIFUNGAL AGENT; CYCLOSPORIN; ENTECAVIR; ETANERCEPT; HEPATITIS B ANTIBODY; MEROPENEM; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VANCOMYCIN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ACUTE GRAFT VERSUS HOST DISEASE; AGED; ARTICLE; ASPERGILLOSIS; BLOOD TRANSFUSION; BONE MARROW BIOPSY; CASE REPORT; DEBRIDEMENT; DIARRHEA; DRUG MEGADOSE; DRUG USE; FEBRILE NEUTROPENIA; HEMOGLOBIN BLOOD LEVEL; HEPATITIS B; HUMAN; LEUKOCYTE COUNT; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MALE; MICROCHIMERISM; NEUTROPHIL COUNT; PANCYTOPENIA; PRIORITY JOURNAL; RASH; REMISSION; RIGOR; SKIN BIOPSY; THROMBOCYTE COUNT; ACUTE DISEASE; CHEMICALLY INDUCED DISORDER; DERMATOMYCOSIS; DRUG ANTAGONISM; GRAFT VERSUS HOST REACTION; IMMUNOLOGY; LIVER CELL CARCINOMA; LIVER TUMOR; TREATMENT OUTCOME; VIROLOGY;

ACUTE DISEASE; AGED; ANTIFUNGAL AGENTS; ASPERGILLOSIS; CARCINOMA, HEPATOCELLULAR; DERMATOMYCOSES; GRAFT VS HOST DISEASE; HEPATITIS B, CHRONIC; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; RECEPTORS, TUMOR NECROSIS FACTOR; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67649232113     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21704     Document Type: Article

References (40)

1. Smith DM, Agura E, Netto G, Collins R, Levy M, Goldstein R, et al. Liver transplant-associated graft-versus-host disease. Transplantation 2003;75:118-126.
2. Knox KS, Behnia M, Smith LR, Vance GH, Busk M, Cummings OW, et al. Acute graft-versus-host disease of the lung after liver transplantation. Liver Transpl 2002;8:968-971.
3. Schoniger-Hekele M, Muller C, Kramer L, Dauber E, Mayr WR, Wrba F, et al. Graft versus host disease after orthotopic liver transplantation documented by analysis of short tandem repeat polymorphisms. Digestion 2006;74: 169-173.
4. Taylor AL, Gibbs P, Sudhindran S, Key T, Goodman RS, Morgan CH, et al. Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation. Transplantation 2004; 77:441-446.
5. Perri R, Assi M, Talwalkar J, Heimbach J, Hogan W, Moore SB, et al. Graft vs. host disease after liver transplantation: a new approach is needed. Liver Transpl 2007;13:1092-1099.
6. Budowle B, Chakraborty R, Giusti AM, Eisenberg AJ, Allen RC. Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE. Am J Hum Genet 1991;48:137-144.
7. Lehner F, Becker T, Sybrecht L, Luck R, Schwinzer R, Slateva K, et al. Successful outcome of acute graft-versus-host disease in a liver allograft recipient by withdrawal of immunosuppression. Transplantation 2002;73:307-310.
8. Chinnakotla S, Smith DM, Domiati-Saad R, Agura ED, Watkins DL, Netto G, et al. Acute graft-versus-host disease after liver transplantation: role of withdrawal of immunosuppression in therapeutic management. Liver Transpl 2007;13:157-161.
9. Sun B, Zhao C, Xia Y, Li G, Cheng F, Li J, et al. Late onset of severe graft-versus-host disease following liver transplantation. Transpl Immunol 2006;16:250-253.
10. Taylor AL, Gibbs P, Bradley JA. Acute graft versus host disease following liver transplantation: the enemy within. Am J Transplant 2004;4:466-474.
11. Jonsson JR, Hogan PG, Thomas R, Steadman C, Clouston AD, Balderson GA, et al. Peripheral blood chimerism following human liver transplantation. Hepatology 1997;25: 1233-1236.
12. Schlitt HJ, Kanehiro H, Raddatz G, Steinhoff G, Richter N, Nashan B, et al. Persistence of donor lymphocytes in liver allograft recipients. Transplantation 1993;56:1001-1007.
13. Domiati-Saad R, Klintmalm GB, Netto G, Agura ED, Chinnakotla S, Smith DM. Acute graft versus host disease after liver transplantation: patterns of lymphocyte chimerism. Am J Transplant 2005;5:2968-2973.
14. Hahn AB, Baliga P. Rapid method for the analysis of peripheral chimerism in suspected graft-versus-host disease after liver transplantation. Liver Transpl 2000;6:180-184.
15. Au WY, Ma SK, Kwong YL, Ng IO, Hawkins BR, Wan TS, et al. Graft-versus-host disease after liver transplantation: documentation by fluorescent in situ hybridisation and human leucocyte antigen typing. Clin Transplant 2000; 14:174-177.
16. Meves A, el-Azhary RA, Talwalkar JA, Moore SB, Brewer JD, Motsonelidze C, et al. Acute graft-versus-host disease after liver transplantation diagnosed by fluorescent in situ hybridization testing of skin biopsy specimens. J Am Acad Dermatol 2006;55:642-646.
17. Key T, Taylor CJ, Bradley JA, Taylor AL. Recipients who receive a human leukocyte antigen-B compatible cadaveric liver allograft are at high risk of developing acute graft-versus-host disease. Transplantation 2004;78: 1809-1811.
18. Soejima Y, Shimada M, Suehiro T, Hiroshige S, Gondo H, Takami A, et al. Graft-versus-host disease following living donor liver transplantation. Liver Transpl 2004;10:460-464.
19. Collins RH Jr, Anastasi J, Terstappen LW, Nikaein A, Feng J, Fay JW, et al. Brief report: donor-derived long-term multilineage hematopoiesis in a liver-transplant recipient. N Engl J Med 1993;328:762-765.
20. Mazzaferro V, Andreola S, Regalia E, Poli F, Doci R, Bozzetti F, et al. Confirmation of graft-versus-host disease after liver transplantation by PCR HLA-typing. Transplantation 1993;55:423-425.
21. Roberts JP, Ascher NL, Lake J, Capper J, Purohit S, Garovoy M, et al. Graft vs. host disease after liver transplantation in humans: a report of four cases. Hepatology 1991; 14:274-281.
22. Romagnuolo J, Jewell LD, Kneteman NM, Bain VG. Graft-versus-host disease after liver transplantation complicated by systemic aspergillosis with pancarditis. Can J Gastroenterol 2000;14:637-640.
23. Schrager JJ, Vnencak-Jones CL, Graber SE, Neff AT, Chari RS, Wright KJ Jr, et al. Use of short tandem repeats for DNA fingerprinting to rapidly diagnose graft-versus-host disease in solid organ transplant patients. Transplantation 2006;81:21-25.
24. Schmuth M, Vogel W, Weinlich G, Margreiter R, Fritsch P, Sepp N. Cutaneous lesions as the presenting sign of acute graft-versus-host disease following liver transplantation. Br J Dermatol 1999;141:901-904.
25. Starzl TE, Demetris AJ, Trucco M, Murase N, Ricordi C, Ildstad S, et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993;17:1127-1152.
26. Whalen JG, Jukic DM, English JC III. Rash and pancytopenia as initial manifestations of acute graft-versus-host disease after liver transplantation. J Am Acad Dermatol 2005;52:908-912.
27. Neumann UP, Kaisers U, Langrehr JM, Muller AR, Blumhardt G, Bechstein WO, et al. Fatal graft-versus-host-disease: a grave complication after orthotopic liver transplantation. Transplant Proc 1994;26:3616-3617.
28. Pageaux GP, Perrigault PF, Fabre JM, Portales P, Souche B, Dereure O, et al. Lethal acute graft-versus-host disease in a liver transplant recipient: relations with cell migration and chimerism. Clin Transplant 1995;9:65-69.
29. Paizis G, Tait BD, Kyle P, Angus PW, Grigg AP. Successful resolution of severe graft versus host disease after liver transplantation correlating with disappearance of donor DNA from the peripheral blood. Aust N Z J Med 1998;28: 830-832.
30. Sudhindran S, Taylor A, Delriviere L, Collins VP, Liu L, Taylor CJ, et al. Treatment of graft-versus-host disease after liver transplantation with basiliximab followed by bowel resection. Am J Transplant 2003;3:1024-1029.
31. Rinon M, Maruri N, Arrieta A, Fernandez JR, Ortiz de Urbina J, Garcia Masdevall MD. Selective immunosuppression with daclizumab in liver transplantation with graft-versus-host disease. Transplant Proc 2002;34:109-110.
32. Kuball J, Theobald M, Ferreira EA, Hess G, Burg J, Maccagno G, et al. Control of organ transplant-associated graft-versus-host disease by activated host lymphocyte infusions. Transplantation 2004;78:1774-1779.
33. Patriarca F, Sperotto A, Damiani D, Morreale G, Bonifazi F, Olivieri A, et al. Infliximab treatment for steroid-refractory acute graft-versus-host disease. Haematologica 2004; 89:1352-1359.
34. Couriel D, Saliba R, Hicks K, Ippoliti C, de Lima M, Hosing C, et al. Tumor necrosis factor-alpha blockade for the treatment of acute GVHD. Blood 2004;104:649-654.
35. Jacobsohn DA, Hallick J, Anders V, McMillan S, Morris L, Vogelsang GB. Infliximab for steroid-refractory acute GVHD: a case series. Am J Hematol 2003;74:119-124.
36. Kobbe G, Schneider P, Rohr U, Fenk R, Neumann F, Aivado M, et al. Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFalpha antibody. Bone Marrow Transplant 2001;28:47-49.
37. Uberti JP, Ayash L, Ratanatharathorn V, Silver S, Reynolds C, Becker M, et al. Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease. Biol Blood Marrow Transplant 2005;11:680-687.
38. Kennedy GA, Butler J, Western R, Morton J, Durrant S, Hill GR. Combination antithymocyte globulin and soluble TNFalpha inhibitor (etanercept) +/- mycophenolate mofetil for treatment of steroid refractory acute graft-versus-host disease. Bone Marrow Transplant 2006;37: 1143-1147.
39. Busca A, Locatelli F, Marmont F, Ceretto C, Falda M. Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. Am J Hematol 2007;82:45-52.
40. Levine JE, Paczesny S, Mineishi S, Braun T, Choi SW, Hutchinson RJ, et al. Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease. Blood 2008;111:2470-2475.